Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Fibrocell Science Inc

+ Add to Watchlist

FCSC:US

3.8600 USD 0.0200 0.52%

As of 11:33:56 ET on 01/29/2015.

Snapshot for Fibrocell Science Inc (FCSC)

Open: 3.8700 Day's Range: 3.7900 - 3.9245 Volume: 27,054
Previous Close: 3.8400 52wk Range: 2.2801 - 6.3000 1-Yr Rtn: -22.49%

Stock Chart for FCSC

No chart data available.
  • FCSC:US 3.8600
  • 1D
  • 1M
  • 1Y
3.8400
Interactive FCSC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FCSC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7241
Est. EPS (USD) (12/2014) -0.6400
Est. PEG Ratio -
Market Cap (M USD) 157.47
Shares Outstanding (M) 40.86
30 Day Average Volume 126,466
Price/Book (mrq) 4.7011
Price/Sale (ttm) 929.9337
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FCSC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FCSC

Fibrocell Science, Inc. is a biotechnology company that develops skin and tissue rejuvenation technologies. The Company's process multiplies the patient's collagen producing cells and returns them to the patient's skin to treat damage caused by aging, the sun, acne, and burns.

David M PernockChairman/CEOKimberly M SmithInterim CFO/Treasurer/Secy
Laura CampbellVP:HR & Business ProcessKaren DonhauserVP:Quality
More Company Profile & Key Executives for FCSC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil